Are melphalan/melphalan tablets on the market?

Melphalan/Melphalan is a chemotherapy drug used to treat many types of cancer, especially in the treatment of multiple myeloma, ovarian cancer, breast cancer, and polycythemia vera. Its mechanism of action is mainly to inhibit the growth and reproduction of tumor cells by interfering with the DNA synthesis and repair of cancer cells. Melphalan is usually administered orally, and the usage and dose need to be adjusted according to the patient's disease type, course and individual differences.

As a non-targeted anti-cancer drug, the marketing situation of Melphalan tablets varies in different regions and time. The drug was first developed by GlaxoSmithKline. It was approved for marketing inthe 1950s, and has been recognized by drug regulatory agencies in many countries, such as the U.S. Food and Drug Administration (FDA). The time to market may vary in different countries and regions, but as a classic chemotherapy drug, its clinical application is relatively mature. Melphalan tablets are marketed in China under the brand name Aikelan®, also known as Melphalan in Chinese. Other dosage forms of melphalan tablets, such as melphalan hydrochloride for injection, are also sold in the Chinese market.

Since Melphalan Tablets are prescription drugs and contain toxic ingredients, you must strictly abide by the doctor's instructions during use, and do not adjust the dosage or interrupt treatment on your own. Patients should obtain and use this drug rationally through proper channels under the guidance of a doctor to protect their own health and safety. In addition, the management measures for its side effects are also gradually improved, allowing patients to better cope with possible adverse reactions when receiving treatment.

Regarding the future development of melphalan, an increasing number of clinical studies are ongoing to explore its potential in novel treatment options. At the same time, with the advancement of biotechnology, research combining targeted drugs and immunotherapy has also opened up new possibilities for the application of melphalan. This not only helps to improve the effectiveness of treatment, but may also reduce the side effects of traditional chemotherapy.